Markets:

Overview

News

Currencies

International

Treasuries

Taysha Gene Therapies, Inc. - Common Stock (NQ:TSHA)

6.810 +0.140 (+2.10%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Taysha Gene Therapies, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

US Stocks Turn Higher After Fed Raises Key Overnight Interest Rate; Nasdaq Up 1.5% ↗

February 01, 2023

U.S. stocks turned higher toward the end of trading, following the release of interest rate decision. The Dow traded up 0.05% to 34,104.56 while the NASDAQ rose 1.58% to 11,767.44. The S&P 500 also...

Via Benzinga

Why WestRock Company Are Trading Lower By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 01, 2023

Gainers Versus Systems Inc. (NASDAQ: VS) surged 270% to $2.26 after the company announced it will partner with Resolve to bring generative AI and gamification to customer payments and credit...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 01, 2023

Via Benzinga

Analyst Ratings for Taysha Gene Therapies ↗

January 27, 2023

Via Benzinga

Expert Ratings for Taysha Gene Therapies ↗

January 04, 2023

Via Benzinga

Expert Ratings for Taysha Gene Therapies ↗

October 26, 2022

Taysha Gene Therapies (NASDAQ:TSHA) has observed the following analyst ratings within the last quarter:

Via Benzinga

Dow Dips 300 Points; Snap Shares Plunge ↗

February 01, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 300 points on Wednesday. The Dow traded down 0.91% to 33,774.70 while the NASDAQ fell 0.33% to 11,546.13. The S&P 500...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023 ↗

February 01, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 01, 2023

Via Benzinga

Why TransCode Therapeutics Shares Are Trading Higher By 42%; Here Are 20 Stocks Moving Premarket ↗

February 01, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

February 01, 2023

It's time for another look at the biggest pre-market stock movers worth checking out as we start off trading early on Wednesday!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 31, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 30, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023 ↗

January 27, 2023

Via Benzinga

JMP Securities Maintains Market Outperform Rating for Taysha Gene Therapies: Here's What You Need To Know ↗

January 19, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 29, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2022 ↗

November 09, 2022

Upgrades

Via Benzinga

Earnings Scheduled For November 8, 2022 ↗

November 08, 2022

Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022 ↗

November 08, 2022

Upgrades

Via Benzinga

Earnings Preview: Taysha Gene Therapies ↗

November 07, 2022

Taysha Gene Therapies (NASDAQ:TSHA) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Taysha...

Via Benzinga

$3 Million Bet On Taysha Gene Therapies? Check Out These 3 Penny Stocks Insiders Are Buying ↗

November 03, 2022

The Dow Jones closed lower by more than 500 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

Why Etsy Shares Are Trading Sharply Higher; Here Are 31 Stocks Moving Premarket ↗

November 03, 2022

Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares rose 34.7% to $0.0858 in pre-market trading after gaining over 12% on Wednesday.

Via Benzinga

Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday ↗

October 28, 2022

Gainers UserTesting, Inc. (NYSE: USER) shares jumped 91.7% to close at $7.40 after the company announced it will be acquired by Thoma Bravo and Sunstone Partners for $1.3 billion. The company also...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 27, 2022

Gainers

Via Benzinga

Why UserTesting Shares Are Trading Higher By Around 93%? Here Are 53 Stocks Moving In Thursday's Mid-Day Session ↗

October 27, 2022

Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) gained 111% to $2.03 after the company announced it entered into a license agreement with Transcosmos Digital Technology for its Apromore process...

Via Benzinga

US Stocks Mostly Higher; Dow Jumps Over 400 Points ↗

October 27, 2022

U.S. stocks traded mostly higher this morning, with the Dow Jones climbing more than 400 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 27, 2022

Gainers Clearside Biomedical (NASDAQ:CLSD) stock rose 27.3% to $1.35 during Thursday's pre-market session. The market value of their outstanding shares is at $81.2 million.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 26, 2022

Gainers

Via Benzinga

Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday ↗

October 27, 2022

Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the...

Via Benzinga

Why Seagate Shares Are Trading Lower By More Than 7%? Here Are 49 Stocks Moving In Wednesday's Mid-Day Session ↗

October 26, 2022

Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares surged 59.3% to $2.7417 after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.